HippoFi Inc (OTCMKTS:ORHB) Stock In Focus After Latest News

A subsidiary of HippoFi Inc (OTCMKTS:ORHB), PUR Biologics on April 6, 2023, announced the launch of a novel moldable synthetic, PURcore. PURcore has an interconnected micro-pore structure for spine surgery promoting bone regeneration and healing.

PUR Biologics is committed to supporting surgeons and hospitals in providing the best care for their patients with a complete line of biologic product options. The company is continuing to demonstrate authority in becoming a best-in-class spinal biologic company.

PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery

CJ Wiggins, Executive Chairman & CEO of HippoFi said that the company is excited about offering PURcore as a cutting-edge product for supporting patient care. Wiggins added that the product has incredible handling properties enabling spine surgeons to intraoperatively implant. This also keeps advanced bioActive material for the healing to occur.

The spine markets and orthopaedicare witnessing growth, with market opportunity for bone growth products at more than $8B and a year-over-year growth rate of 6%.

Ryan Fernan, Head of PUR Biologics expressed delight in launching PURcore and giving a fresh option for surgeons for enhancing patient outcomes. Fernan added that the early feedback from customers has been positive. Fernan is confident on PURcore to be an amazing addition to the company’s market-leading portfolio of products.